The transactivation and p53-interacting functions of hepatitis B virus X protein are mutually interfering but distinct

Cancer Research

Volumn 57, Issue 22, 1997, Pages 5137-5142

  Lin, Yong ^a   Nomura, Takahiro ^a   Yamashita, Tatsuya ^a   Dorjsuren, Dorjbal ^a   Tang, Hong ^a   Murakami, Seishi ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE TRANSFERASE; PROTEIN P53; VIRUS PROTEIN;

ARTICLE; BINDING SITE; DNA BINDING; GENE EXPRESSION; GENETIC TRANSFECTION; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; IMMUNOBLOTTING; LIVER CARCINOGENESIS; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; TRANSACTIVATION;

BINDING SITES; BLOTTING, WESTERN; CHLORAMPHENICOL O-ACETYLTRANSFERASE; GENES, P53; GENES, REPORTER; SEQUENCE HOMOLOGY, AMINO ACID; TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0030724749     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Beasly, R. P. Hepatitis B virus. The major etiology of hepatocellular carcinoma. Cancer (Phila.), 61: 1942-1956, 1988.
2. Buendia, M. A., Hepatitis B viruses and hepatocellular carcinoma. Adv. Cancer Res., 59: 167-226 1992.
3. Duflot, A., Mehrotra, R., Yu, S. Z., Barraud, L., Trepo, C., and Cova, L. Spectrum of liver disease and duck hepatitis B virus infection in a large series of Chinese ducks with hepatocellular carcinoma. Hepatology, 21: 1483-1491, 1995.
4. Hohne, M., Schaefer, S., Seifer, M., Feitelson, M. A., Pual, D., and Gerlich, W. H. Malignant transformation of immortalized transgenic hepatocytes after transfection with hepatitis B virus DNA. EMBO J., 9: 1137-1145, 1990.
5. Rakotomahanina, C. K., Hilger, C., Fink, T., Zentgraf, H., and Schroder, C. H. Biological activities of a putative truncated hepatitis B virus X gene product fused to a polylysin stretch. Oncogene, 9: 2613-2621, 1994.
6. Oguey, D., Dumenco, L. L., Pierce, R. H., and Fausto, N. Analysis of the tumorigenicity of the X gene of hepatitis B virus in a noutransformed hepatocyte cell line and the effects of cotransfection with a murine p53 mutant equivalent to human codon 249. Hepatology, 24: 1024-1033, 1996.
7. Kim, C. M., Koike, K., Saito, I., Miyamura, T., Jay, G. HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature (Lond.), 351: 317-320, 1991.
8. Koike, K., Moriya, K., Iino, S., Yotsuyanagi, H., Endo, Y., Miyamura, T., and Kurokawa, K. High-level expression of hepatitis B virus HBx gene and hepatocarcinogenesis in transgenic mice. Hepatology, 19: 810-819, 1994.
9. Slagle, B. L., Lee, T. H., Medina, D., Finegold, M. J., and Butel, J. S. Increased sensitivity to the hepatocarcinogen diethylnitrosamine in transgenic mice carrying the hepatitis B virus X gene. Mol. Carcinog., 15: 261-269, 1996.
10. Terradillos, O., Billet, O., Renard, C. A., Levy, R., Molina, T., Briand, P., and Buendia, M. A. The hepatitis B virus X gene potentiates c-myc-induced liver oncogenesis in transgenic mice. Oncogene, 14: 395-404, 1997.
11. Wei, Y., Etiemble, J., Fourel, G., Vitvitski-Trepo, L., and Buendia, M. A. Hepadna virus integration generates virus-cell cotranscripts carrying 3′ truncated X genes in human and woodchuck liver tumors. J. Med. Virol., 45: 82-90, 1995.
12. Paterlini, P., Poussin, K., Kew, M., Franco, D., and Brechot, C. Selective accumulation of the X transcript of hepatitis B virus in patients negative for hepatitis B surface antigen with hepatocellular carcinoma. Hepatology, 21: 313-321, 1995.
13. Greenblatt, M. S., Feitelson, M. A., Zhu, M., Bennett, W. P., Welsh, J. A., Jones, R., Borkowski, A., and Harris, C. C. Integrity of p53 in hepatitis B x antigen-positive and -negative hepatocellular carcinomas. Cancer Res., 57: 426-432, 1997.
14. Benn, J., and Schneider, R. J. Hepatitis B virus HBx protein deregulates cell cycle checkpoint controls. Proc. Natl. Acad. Sci. USA, 92: 11215-11219, 1995.
15. Avantaggiati, M., Natoli, G., Balsano, C., Chirillo, P., Artini, M., Collepardo, D. D., and Levrero, M. The hepatitis B virus (HBV) pX transactivate the c-fos promoter through multiple cis-acting elements. Oncogene, 8: 1567-1574, 1993.
16. Benn, J., and Schneider, R. J. Hepatitis B virus HBx protein activates Ras-GTP complex formation and establishes a Ras, Raf, MAP kinase signaling cascade. Proc. Natl. Acad. Sci. USA, 91: 10350-10354, 1994.
17. Seto, E., Yen, T. S., Peterlin, B. M., and Ou, J. H. Trans-activation of the human immunodeficiency virus long terminal repeat by the hepatitis B virus X protein. Proc. Natl. Acad. Sci. USA, 85: 8286-8290, 1988.
18. Su, F., and Schneider, R. J. Hepatitis B virus HBx protein activates transcription factor NF-kB by acting on multiple cytoplastic inhibitors of rel-related proteins. J. Virol., 70: 4558-4566, 1996.
19. Twu, J. S., Chu, K., and Robinson, W. S. Hepatitis B virus X gene activates kappa B-like sequence in the long terminal repeat of human immunodeficiency virus 1. Proc. Natl. Acad, Sci. USA, 86: 5168-5172, 1989.
20. Mahe, Y., Mukaida, N., Kuno, K., Akiyama, M., Ikeda. N., Matsushima, K., and Murakami, S. Hepatitis B virus X protein transactivates human interleukin-8 gene through acting on nuclear factor KB and CCAAT/enhancer-binding protein-like cis-elements. J. Biol. Chem., 266: 13759-13763, 1991.
21. Hu, K. Q., Vierling, J. M., and Siddiqui, A. Trans-activation of HLA-DR gene by hepatitis B virus X gene product. Proc. Natl. Acad. Sci. USA, 87: 7140-7147, 1990.
22. Twu, J. S, Lai, M. Y., Chen, D. S., and Robinson, W. S. Activation of proto-oncogene c-jun by the X protein of hepatitis B virus. Virology, 192: 346-350, 1993.
23. Yen, B. T. S. Hepadnaviral X protein: review of recent progress. J. Biomed. Sci., 3: 20-30, 1996.
24. Lane, D. P. Cancer: p53, guardian of the genome. Nature (Lond.), 358: 15-16, 1992.
25. Wu, X., and Levine, A., J. p53 and E2F-1 cooperate to mediate apoptosis. Proc. Natl. Acad. Sci. USA, 91: 23602-23606, 1994.
26. Wang, X. W., Vermeulen, W., Coursen, J. D., Gibson, M., Lupold, S. E., Forrester, K., Xu, G., Elmore, L., Yeh, H., Hoeijmakers, J. H., and Harris, C. C. The XPB and XPD DNA helicases are components of the p53-mediated apoptosis pathway. Genes Dev., 10: 1219-1232, 1996.
27. 1 arrest. Cell, 76: 1013-1023, 1994.
28. Donehower, L. A., and Bradley, A. The tumor suppressor p53. Biochem. Biophys. Acta, 1155: 181-205, 1993.
29. McCarthy, S. A., Symonds, H. S., van Dyke, T. Regulation of apoptosis in transgenic mice by simian virus 40 T antigen-mediated inactivation of p53. Proc. Natl. Acad. Sci. USA, 91: 3979-3983, 1994.
30. Debbas, M., and White, E. Wild type p53 mediates apoptosis by E1A, which is inhibited by E1B. Genes Dev., 7: 546-554, 1993.
31. Feitelson, M. A., Zhu, M., Duan, L. X., and London, W. T. Hepatitis B X antigen and p53 are associated in vitro and in liver tissues from patients with primary hepatocellular carcinoma. Oncogene, 8: 1109-1117, 1993.
32. Wang, X. W., Forrester, K., Yeh, H., Feitelson, M. A., Gu, J. R., and Harris, C. C. Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3. Proc. Natl. Acad. Sci. USA, 91: 2230-2234, 1994.
33. Truant, R., Antunovic, J., Greenblatt, J., Prives, C., and Cromlish, J. A. Direct interaction of the hepatitis B virus HBx protein with p53 leads to inhibition by HBx of p53 response element-directed transactivation. J. Virol., 69: 1851-1859, 1995.
34. Ueda, H., Ullrich, S. J., Gangemi, J. D., Kappel, C. A., Ngo, L., Feitelson, M. A., and Jay, G. Functional inactivation but not structural mutation of p53 causes liver cancer. Nat. Genet., 9: 41-47, 1995.
35. Lee, H., Lee, Y-H., Huh, Y-S., Moon, H., and Yun, Y. X-gene product antagonize the p53-mediated inhibition of hepatitis B virus replication through regulation of the pregenomic/core promoter. J. Biol. Chem., 270: 31405-31412, 1995.
36. Wang, X. W., Gibson, M. K., Vemeulen, W., Yeh, H., Forrester, K., Sturzbecher, H-W, Hoeijmakers, J. H. J., and Harris, C. C. Abrogation of p53-induced apoptosis by the hepatitis B virus X gene. Cancer Res., 52: 6012-6016, 1995.
37. Murakami, S., Cheong, J. H., and Kaneko, S. Human hepatitis B virus X gene encodes a regulatory domain that represses transactivation of X protein. J. Biol. Chem., 269: 15118-15123, 1994.
38. Cheong, J. H., Yi, M., Lin, Y., and Murakami. S. Human RPB5, a subunit shared by eukaryotic nuclear RNA polymerases, binds human hepatitis B virus X protein and may play a role in X transactivation. EMBO J., 14: 142-150, 1995.
39. Lin, Y., Nomura, T., Cheong, J. H., Dorjsuren, D., Iida, K., and Murakami, S. Hepatitis B virus X protein is a transcriptional modulator that communicate with transcription factor UB and the RNA polymerase II subunit 5. J. Biol. Chem., 272: 7132-7139, 1997.
40. 2 terminus with presumptive regulatory motifs in a human TATA factor (TFIID) Nature (Lond.), 346: 387-390, 1990.
41. Kern, S. E., Pietenpol, J. A., Thiagalingam, S., Seymour, A., Kinzler, K. W., and Vogelstein, B. Oncogenic forms of p53 inhibit p53-regulated gene expression. Science (Washington DC), 256: 827-830, 1992.
42. Murakami, S., Cheong, J. H., Ohno, S., Matsushima, K., and Kaneko, S. Transactivation of human hepatitis B virus X protein, HBx, operates through a mechanism distinct from protein kinase C and okadaic acid activation pathways. Virology, 199: 243-246, 1994.
43. Cho, Y., Gorina, S., Jeffrey, P. D., and Pavletich, N. P. Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. Science (Washington DC), 265: 346-355, 1994.
44. Ko, L. J., and Prives, J. p53, puzzle and paradigm. Genes Dev., 10: 1054-1072.
45. Subler, M. A., Martin, D. W., and Deb, S. Overlapping domains on the p53 protein regulate its transcriptional activation and repression functions. Oncogene, 9: 1351-1359, 1994.
46. Liu, X., Miller, C. W., Koeffler, P. H., and Berk, A. J. The p53 activation domain binds the TATA box-binding polypeptide in Holo-TFIID, and a neighboring p53 domain inhibits transcription. Mol. Cell. Biol., 13: 3291-3300, 1993.
47. Thut, C. J., Chen, J-L., Klemm, R., and Tjian, R. p53 transcriptional activation mediated by coactivators TAFII40 and TAFII60. Science (Washington DC), 267: 100-104, 1995.
48. Mosner, J., Mummerbrauer, T., Bauer, C., Sczakiel, G., Grosse, F., and Deppert, W. Negative feedback regulation of wild-type p53 biosynthesis. EMBO J., 14: 4442-4449, 1995.
49. Kubbutat, M., H., and Vousden, K., H. Proteolytic cleavage of human p53 by calpain: potential regulator of protein stability. Mol. Cell. Biol., 17: 460-468, 1997.
50. Haupt, Y., Maya, R., Kazaz, A., and Oren, M. Mdm2 promotes the rapid degradation of p53. Nature (Lond.), 387: 296-299, 1997.
51. Fu, L., and Benchimol,. S. Participation of the human p53 3′UTR in translational repression and activation following γ-irradiation. EMBO J., 16: 4117-4125, 1997.